Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
AMBS continues to rise this week, Alerted last week here at .06
Expecting new positive news on a JV to advance Diagnostic Blood Tests to Market with a potential $800 Million per year revenue Stream.
GL2ALL
Zoom
$800 Million Revenue Generating Potential coming into the picture fast and furiously ..
Get in or add more now..
Dr. Simon is a world-renowned expert in working with Alzheimer's disease biomarkers, and also has significant expertise in the development of in-vitro diagnostics;
http://seekingalpha.com/instablog/200555-qualitystocks/1713571-dr-adam-j-simon-joins-amarantus-bioscience-inc-ambs-board-of-advisors
AMBS Diagnostic DD google doc.Wow Stockboardassets group is really doing a great job in keeping the street updated.
https://docs.google.com/a/students.towson.edu/document/d/1ihv24O8iUYILQocEtGTicKO7UJtaMQiUmUr_5hEbFL0/edit
Check it out and the Major Revenue Generating part of AMBS coming into play here...
GL2ALL
ZOOM
800 MILLION IN REVENUE..... tic toc tic toc...
AMBS Diagnostics will be legendary soon. then ADD MANF.... WOW..
Hold on take off has started we are leaving the tower... You still can jump on.
internal priorities are shifting with the emergence of new information regarding the market demand for LymPro; and we are planning for significant growth in the second quarter. Management believes we are on the right path to achieve success for all stakeholders involved in Amarantus, most importantly patients.
AMBS about to announce JV to take to market Diagnostic Tests that can generate 800 Million dollars in revenue as early as end of 2013. Get in or add more already on its run. GL2ALL
no its not... but don't forget the knee pads and chapstik
AMBS will mail you a life raft next week after the JV announcement
AMBS “The data on MANF continues to return more favorable results than other molecules currently in clinical development as disease-modifying treatments for Parkinson’s disease,” said Dr. Joseph Rubinfeld, Amgen co-founder and current member of the Company’s Board of Advisors. “We intend to conduct select additional experiments to understand why this appears to be the case while we continue the IND-enabling studies that have already been initiated. We believe these additional data points will further distinguish MANF from competitors in the field, and will deliver significant value in the near-term.”
I can make bold letters too.. minus the caps
I'll take his words over some squeaky wheel
Thanks i agree. But i think your revenue estimates are very conservative. But i'll take that
AMBS Diagnostics. = $$$$$$$$$$$
Both Lympro and Nuropro blood tests are at Clinical stage 2. Meaning 800 Million per year revenue potential is closer than most people think. I don't know what some of these cats before me are talking about and i don't think they even know themselves and i really do not care. AMBS is set to fly. No one can stop it. Its the inevitable.
I don't like speaking for others but.. yes that is correct they met AMBS CEO Gerald and even the CEO Jackson from Banyan
they arranged meeting way in advance with Gerald, we all know he is a very accessible CEO...
GL2ALL
I'm the one taking the picture
very True thanks for the correction... AMBS
I prefer not to imply I am smarter than the next person by saying what I used to do.. But I know that it is smart to buy more AMBS now before next week
IMO you should not be a moderator on the AMBS board if you are biased.
this can be your second post you delete if you like..
have a wonderful evening
Banyan & AMBS news approaching .. GL2ALL
AMBS. Diagnostics. 800 million revenue potential is fueling this upward jump. You heard it before it happened. Still not too late.
AMBS. Diagnostics. 800 million revenue potential is fueling this upward jump. You heard it here before it happened. Still not too late.
yes.. AMGEN got a steal for Synergen.. they were trading the previous year..for 6 or 7 times more than what AMGEN ended paying per share
AMBS has exciting times ahead
Whale sightings. AMBS
Engines are revving up.
Get on Next the next take off if AMBS
Nice call. Rocket ship
You Will. Thanks have a nice day.
AMBS about to announce JV to take to market Diagnostic Tests that can generate 300-800 Million dollars in revenue as early as end of 2013.
Get in or add more.
GL2ALL
AMBS about to announce JV to take to market Diagnostic Tests that can generate 300-800 Million dollars in revenue as early as end of 2013.
Get in or add more.
GL2ALL
800 MILLION IN REVENUE..... tic toc tic toc...
AMBS Diagnostics will be legendary soon. then ADD MANF.... WOW..
Hold on for take off.... NEWS Coming Soon or Shortly as Gerald likes to say
GL2ALL
Do not forget that the delivery for MANF for other indications such as Ischemic Heart Disease especially myocardial infarction is much more simple.
and besides as AMBS CEO stated in his before last presentation they are in talks with 2 Companies that have new and much more effiecient methods of delivering MANF to where it need to be in the Brain.
http://www.amarantus.com/therapeutics/ischemic-heart-disease
His Guess is as good as yours.. he would not know he can only speculate. but I myself know something is coming and that is the Easter Bunny AMBS
GL2ALL
your answer is in the 8k's :
All that report tells me is that the Short Sellers know whats coming and they are not as Gutsy as they used to be with AMBS.. the MM's are still shaking weaks out and trying to cover themselves.. TBD.. April can't come soon enough GL2ALL
Leave to the order in how many shares? I will buy on. monday.
Why would they pay you .051. When they were getting .05 ?
How would he know?
IND comes before NDA. I'm surprised Dr J didn't know that. But he plays one on TV so what can we expect. Either way this should move PPS up.
GL2ALL
more like : AMBS files for IND
To legally test the drug on human subjects in the U.S., the maker must first obtain an Investigational New Drug (IND) designation from FDA. This application is based on pre-clinical data, typically from animal studies, that shows the drug is safe enough to be tested in humans.
http://agilawritingblog.blogspot.com/2010/08/difference-between-ind-nda-and-anda.html
Its not recycled read it again. These are tests showing that MANF works as a preventative treatment. AMBS
Im starting to think you are Dr Saarma from Hemopharma who lost the patent challenge vs AMBS
i agree seriously
did you know one of AMBS MANF's competitors sued them regarding the patent on MANF and lost? did you know this... competitors know what AMBS has:
Dec 5th,2012
Amarantus Bioscience, Inc. (otcqb:AMBS) recently had a major victory when its patent for MANF, the company's proprietary anti-apoptosis therapeutic protein, was challenged in Europe.
http://ir.stockpr.com/amarantus/company-news/detail/363/amarantus-biosciences-wins-manf-patent-challenge-in-europe
The Opposition Division of the European Patent Office upheld Amarantus' European Patent relating to the neurotrophic factor following opposition by rival Hermo Pharma OY of Finland.
The Opposition Division held that Hermo Phrama's arguments did not prejudice the maintenance of the patent as originally granted, with broad claims covering MANF and its derivatives. The Opponent had not contested the validity of the patent on the basis of novelty or inventive step, but had objected to the broad scope of the claims. After due consideration, the Opposition Division rejected the Hermo Pharma's arguments and upheld the claims without restriction.
"This is a highly significant decision for Amarantus, after an extended period of uncertainty," said Marc Wilkinson PhD, European Patent Attorney of UK firm Avidity IP, representing Amarantus. "The Opposition Division's decision validates broad protection for MANF and derivatives across major European jurisdictions."
AMBS's plan is in motion..
But AMBS CEO does take the time to meet with some of his private Investors at their request. which is something that needs to be noted.